|
|
|
| Join The Advancing RNA Community | Introducing Advancing RNA, an online community designed to be a forum and resource for professionals working on RNA-based therapeutics to better understand the challenges that confront them in areas like Analytical/Quality, Manufacturing, Formulation, Outsourcing, Clinical Research, and Supply Chain/Logistics. Sign up for the Advancing RNA newsletter, delivered to your inbox weekly. |
|
|
|
|
Executives responding to this year’s finance and funding outlook questions are optimistic about the potential for a turnaround in 2024. |
|
|
|
Just under one-third of respondents who participated in ISR’s Oral Dosage Forms Market Outlook research shared that familiarity/history of working together/prior positive experience are the reasons behind their preferences. |
|
|
|
Finding scientific talent is an arduous process, often stealing precious time from our calendars. Furthermore, hiring well doesn’t have to be left to chance. Try these specific actions. |
|
|
|
|
|
|
| Rapid Characterization Of Impurities | Understand how to manage impurities in drug development with swift isolation, synthesis, and analysis. A client discovered an impurity that exceeded ICH guidelines during ongoing stability studies. |
|
|
|
|
Inside you will find more on: - Supply Chain Outlook
- Next-Gen RNA Therapeutics
- Moving Beyond AAV
- Biopharma Reputation Challenge
View the digital edition. |
|
|
CONTRIBUTE TO LIFE SCIENCE LEADER |
|
|
|
Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director. |
|
|
Connect With Life Science Leader: |
|
|
|